UNSPSC 51161518: Pranlukast

This classification denotes an anti-asthmatic agent and leukotriene antagonist with the molecular formula C27H23N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TB8Z891092, chemically known as benzamide, n-(4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)- but generally known as pranlukast, which bears US NIH Compound Identifier 115100. European Medicines Agency schedules Pranlukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09998MIG.

UNSPSC 51161518 Pranlukast is a Commodity code for a specific pharmaceutical active ingredient used in asthma and allergic airway disease treatment. State and local governments procure this product primarily through public health agencies, corrections departments, and school district health services for inclusion in formularies, emergency medical supplies, and chronic disease management programs. The work involves purchasing finished pharmaceutical products or bulk active pharmaceutical ingredient for compounding into finished dosage forms, typically through state pharmaceutical contracts, group purchasing organizations, or direct procurement via IFB and RFQ processes. Issuing bodies include state departments of health, state prison systems, county health departments, and independent school districts with on-site medical clinics or student asthma management protocols.

The source provided contains no recent state and local contract opportunities tagged to UNSPSC 51161518 Pranlukast. Without posted solicitations naming this code, geographic concentration and representative recent opportunities cannot be determined from available records.